The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine

Monoclonal antibodies are leading agents for therapeutic treatment of human diseases, but are limited in use by the paucity of clinically relevant models for validation. Sporadic canine tumours mimic the features of some human equivalents. Developing canine immunotherapeutics can be an approach for...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Saurabh, Aresu, Luca, Comazzi, Stefano, Shi, Jianguo, Worrall, Erin, Clayton, John, Humphries, William, Hemmington, Sandra, Davis, Paul, Murray, Euan, Limeneh, Asmare A., Ball, Kathryn, Ruckova, Eva, Muller, Petr, Vojtesek, Borek, Fahraeus, Robin, Argyle, David, Hupp, Ted R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760772/
https://www.ncbi.nlm.nih.gov/pubmed/26894679
http://dx.doi.org/10.1371/journal.pone.0148366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760772/
https://www.ncbi.nlm.nih.gov/pubmed/26894679
http://dx.doi.org/10.1371/journal.pone.0148366

Ejemplares similares